BACKGROUND: Today's diabetes-oriented telemedicine systems can gather and analyze many parameters like blood glucose levels, carbohydrate intake, insulin doses, and physical activity levels (steps). Information collected can be presented to patients in a variety of graphical outputs. Despite the availability of several technical means, a large percentage of patients do not reach the goals established in their diabetes treatment. OBJECTIVE: The objective of the study was to evaluate the benefits of the Diani telemedicine system for the treatment of patients with type 1 diabetes mellitus. METHODS: Data were collected during a 24-week feasibility study. Patients responded to the World Health Organization Quality of Life - BREF (WHOQOL-BREF) questionnaire and a system evaluation questionnaire. The level of glycated hemoglobin (HbA1c) and the patient's body weight were measured, and the patient's use of the telemedicine system and their daily physical activity level were monitored. All data were sent from the patient's device to the Diani server using a real-time diabetes diary app. Wilcoxon and Friedman tests and the linear mixed effects method were used for data analysis. RESULTS: This study involved 10 patients (men: n=5; women: n=5), with a mean age of 47.7 (SD 19.3) years, a mean duration of diabetes of 10.5 (SD 8.6) years, and a mean HbA1c value of 59.5 (SD 6.7) mmol/mol. The median number of days the patients used the system was 84. After the intervention, the mean HbA1c decreased by 4.35 mmol/mol (P=.01). The patients spent 18.6 (SD 6.8) minutes on average using the app daily. After the intervention, the number of patients who measured their blood glucose level at least 3 times a day increased by 30%. The graphical visualization of the monitored parameters, automatic transmission of measured data from the glucometer, compatibility, and interconnection of individual devices when entering data were positively evaluated by patients. CONCLUSIONS: The Diani system was found to be beneficial for patients with type 1 diabetes mellitus in terms of managing their disease. Patients perceived it positively; it strengthened their knowledge of diabetes and their understanding of the influences of the measured values on the management of their disease. Its use had a positive effect on the HbA1c level.
- Publikační typ
- časopisecké články MeSH
We performed a search to identify available wearable sensors systems that can collect patient health data and have data sharing capabilities. Findings available in "Wearable sensors with possibilities for data exchange: Analyzing status and needs of different actors in mobile health monitoring systems" [1]. We performed an initial search of the Vandrico wearable database, and supplemented the resulting device list with an internet search. In addition to relevant meta-data (i.e. name, description, manufacturer, web-link, etc.) for each device, we also collected data on 13 attributes related to data exchange. I.e. device type, communication interface, data transfer protocol, smartphone and/or PC integration, direct integration to open health platform, 3rd platform integration with open health platform, support for health care system/middleware connection, recorded health data types, integrated sensors, medical device certification, whether or not the use can access collected data, device developer access, and device availability on the market. In addition, we grouped each device into three groups of actors that these devices are relevant for: electronic health record providers, software developers, and patients. The collected data can be used as an overview of available devices for future researchers with interest in the mobile health (mHealth) area.
- Publikační typ
- časopisecké články MeSH